Zoliflodacin show promise against drug resistant infection urogenital gonorrhoea
Luckey et al., 2025(The Lancet): An international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial was conducted. The study...
Read moreLuckey et al., 2025(The Lancet): An international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial was conducted. The study...
Read moreLectus urna duis convallis convallis tellus. Metus dictum at tempor commodo ullamcorper a. Potenti nullam ac tortor vitae purus faucibus. Massa ultricies mi quis hendrerit dolor magna eget.